Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | GLA | P06280 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | NQO2 | P16083 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7914703 | 0.87 | PDGFRB (0.50) | ALDH1A1GLAHPGDACHEMAPT | |
| SCHEMBL1217656 | 0.83 | GSTP1 (0.40) | ALDH1A1GLAHPGDACHEMAPT | |
| SCHEMBL6948594 | 0.82 | PDGFRB (0.53) | ALDH1A1MAPTNPC1POLBRAB9A | |
| SCHEMBL7374427 | 0.79 | ADORA2A (0.41) | ALDH1A1GLAHPGDACHEMAPT | |
| SCHEMBL9089858 | 0.79 | PDGFRB (0.39) | ALDH1A1GLAHPGDACHEMAPT | |
| SCHEMBL1385432 | 0.77 | ALDH1A1 (0.42) | ALDH1A1GLAHPGDACHEMAPT | |
| SCHEMBL523809 | 0.76 | RAB9A (0.44) | ALDH1A1GLAHPGDACHEMAPT | |
| SCHEMBL641339 | 0.75 | ALDH1A1 (0.47) | ALDH1A1GLAHPGDACHEMAPT | |
| SCHEMBL2320187 | 0.74 | KDM4E (0.47) | ALDH1A1HPGDMAPTKDM4EL3MBTL1 | |
| SCHEMBL2278930 | 0.74 | NPC1 (0.51) | ALDH1A1GLAHPGDACHEMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024119977-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMISSION DIODE DEVICE COMPRISING SAME | 四川阿格瑞新材料有限公司 | 2024-06-13 | — | — | WO | claimed |
| US-20230276705-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-08-31 | — | — | US | claimed |
| CN-116574131-A | Electron transport material and application thereof in electroluminescent device | 四川阿格瑞新材料有限公司 | 2023-08-11 | — | — | CN | claimed |
| US-11690291-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | LG DISPLAY CO., LTD. (KR) | 2023-06-27 | — | — | US | claimed |
| CN-115117267-A | Organic electroluminescent device and display device | 云谷（固安）科技有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-110970570-B | Organic electroluminescent device | 乐金显示有限公司 | 2022-08-12 | — | — | CN | claimed |
| EP-3633752-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE | LG DISPLAY CO LTD (KR) | 2021-12-22 | — | — | EP | claimed |
| US-20210074928-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2021-03-11 | — | — | US | claimed |
| CN-112409351-A | Organic compound, and organic light emitting diode and organic light emitting display device including the same | 乐金显示有限公司 | 2021-02-26 | — | — | CN | claimed |
| EP-3633752-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | LG Display Co., Ltd. (KR) | 2020-04-08 | — | — | EP | claimed |
| EP-1530573-B1 | CONDENSED HETEROCYCLIC PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PFIZER ITALIA SRL (IT) | 2008-03-19 | — | — | EP | claimed |
| JP-2007515442-A | — | — | 2007-06-14 | — | — | JP | claimed |
| US-7183280-B2 | Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-02-27 | — | — | US | claimed |
| EP-1709049-A1 | BICYCLIC IMIDAZOLE COMPOUNDS, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS | Boehringer Ingelheim International GmbH (DE) | 2006-10-11 | — | — | EP | claimed |
| WO-2005063750-A1 | BICYCLIC IMIDAZOLE COMPOUNDS, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-07-14 | — | — | WO | claimed |
| US-20050143377-A1 | Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-06-30 | — | — | US | claimed |
| EP-0611003-B1 | Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity | MERCK & CO INC (US) | 1997-06-18 | — | — | EP | claimed |
| US-5451677-A | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity | MERCK & CO., INC. (US) | 1995-09-19 | — | — | US | claimed |
| WO-1994018161-A1 | SUBSTITUTED PHENYL SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY | MERCK & CO., INC. (US) | 1994-08-18 | — | — | WO | claimed |
| EP-0611003-A1 | Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity | MERCK & CO. INC. (US) | 1994-08-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143377-A1 | Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions | DPP4, DPP3, DPP7 | ALDH1A1 434/4885GLA 1844/4885HPGD 2313/4885 |
| US-11690291-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | OCIAD1, OCIAD2, AOX1 | ALDH1A1 51/4885GLA 1916/4885HPGD 2250/4885 |
| US-20230276705-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | OCIAD1, OCIAD2, AOX1 | ALDH1A1 51/4885GLA 1916/4885HPGD 2250/4885 |
| US-20210074928-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | OCIAD1, OCIAD2, AOX1 | ALDH1A1 51/4885GLA 1916/4885HPGD 2250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.